BVAXF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jun 5 closing price
Capitalization
8.58M
SQZB
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jun 6 closing price
Capitalization
825.75K
62 days until earnings call
Interact to see
Advertisement

BVAXF vs SQZB

Header iconBVAXF vs SQZB Comparison
Open Charts BVAXF vs SQZBBanner chart's image
BioVaxys Technology
Price$0.03
Change-$0.00 (-0.00%)
Volume$40.84K
Capitalization8.58M
SQZ Biotechnologies
Price$0.03
Change-$0.00 (-0.00%)
Volume$59.56K
Capitalization825.75K
BVAXF vs SQZB Comparison Chart
Loading...
View a ticker or compare two or three
VS
BVAXF vs. SQZB commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BVAXF is a Hold and SQZB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (BVAXF: $0.03 vs. SQZB: $0.03)
Brand notoriety: BVAXF and SQZB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BVAXF: 4% vs. SQZB: 228%
Market capitalization -- BVAXF: $8.58M vs. SQZB: $825.75K
BVAXF [@Biotechnology] is valued at $8.58M. SQZB’s [@Biotechnology] market capitalization is $825.75K. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BVAXF’s FA Score shows that 0 FA rating(s) are green whileSQZB’s FA Score has 1 green FA rating(s).

  • BVAXF’s FA Score: 0 green, 5 red.
  • SQZB’s FA Score: 1 green, 4 red.
According to our system of comparison, both BVAXF and SQZB are a bad buy in the long-term.

Price Growth

BVAXF (@Biotechnology) experienced а -2.64% price change this week, while SQZB (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

BVAXF is expected to report earnings on Mar 31, 2025.

SQZB is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
BVAXF($8.58M) has a higher market cap than SQZB($826K). SQZB YTD gains are higher at: -6.667 vs. BVAXF (-30.260).
BVAXFSQZBBVAXF / SQZB
Capitalization8.58M826K1,039%
EBITDA-4.13MN/A-
Gain YTD-30.260-6.667454%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash157KN/A-
Total Debt67.7KN/A-
FUNDAMENTALS RATINGS
BVAXF: Fundamental Ratings
BVAXF
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AZ8.980.41
+4.78%
A2Z Cust2Mate Solutions Corp
BUSE22.730.50
+2.25%
First Busey Corp
CM68.830.12
+0.17%
Canadian Imperial Bank of Commerce
MDU16.800.01
+0.06%
MDU Resources Group
PLUR4.75-0.03
-0.61%
Pluri

BVAXF and

Correlation & Price change

A.I.dvisor tells us that BVAXF and GSGTF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BVAXF and GSGTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BVAXF
1D Price
Change %
BVAXF100%
N/A
GSGTF - BVAXF
29%
Poorly correlated
N/A
THTX - BVAXF
24%
Poorly correlated
-1.90%
EDSA - BVAXF
21%
Poorly correlated
-6.63%
CSBR - BVAXF
21%
Poorly correlated
+6.00%
SQZB - BVAXF
14%
Poorly correlated
-6.67%
More

SQZB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SQZB has been loosely correlated with MDGL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if SQZB jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SQZB
1D Price
Change %
SQZB100%
-6.67%
MDGL - SQZB
33%
Loosely correlated
+1.51%
ARRY - SQZB
33%
Loosely correlated
+1.35%
AXON - SQZB
33%
Poorly correlated
+1.52%
MIST - SQZB
31%
Poorly correlated
-0.57%
LYRA - SQZB
29%
Poorly correlated
-4.15%
More